• Mashup Score: 0

    April 5, 2022 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients in the U.S. with slow heart rhythms. This marks significant advancement for patient care and brings new, never-before-seen features to patients and their physicians. The Aveir leadless pacemaker is implanted directly inside…

    Tweet Tweets with this article
    • @DAICeditor @AbbottCardio #Abbott’s #Aveir single chamber (#VR) pacing system is the world’s only #leadless #pacemaker with a unique mapping capability to assess correct positioning prior to placement: https://t.co/UufJGC7WGB

  • Mashup Score: 0

    Mark Nicholls speaks to Dr Christophe Garweg about a first-in-Europe procedure and how a next-generation wireless mini-pacemaker will benefit more patients

    Tweet Tweets with this article
    • Wireless dual-chamber mini pacemaker and leadless AV synchronous pacing: second generation of leadless device #leadless #pacing #new technology @escardio https://t.co/w3xbVIPPQJ